Huifang Lv

Roles and inhibitors of FAK in cancer: current advances and future directions

Hui-Hui Hu, Saiqi Wang, Hai-Li Shang et al. · Frontiers in Pharmacology · 2024 · 56 citations · Full text

Fak Inhibitors, Cell Death, Cancer Biology +16

Long non‐coding <scp>RNA NNT</scp>‐<scp>AS</scp>1 sponges miR‐424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer

Beibei Chen, Zhao Qingfang, Lulu Guan et al. · Journal of Cellular and Molecular Medicine · 2018 · 48 citations · Full text

Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

Saiqi Wang, Qiu‐Xu Teng, Shuai Wang et al. · Acta Pharmaceutica Sinica B · 2022 · 32 citations · Full text

MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16

Huifang Lv, Hong-Lin Hou, Huijun Lei et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2019 · 30 citations · Full text

Gastric Cancer Cells, Pathology, Cancer Biology +18

Characterization and effects of miR-21 expression in esophageal cancer

Shu Wen Wen, Yuhao Zhang, Yan Li et al. · Genetics and Molecular Research · 2015 · 27 citations · Full text

Tumor Biology, Mir-21 Expression, Oncology +12